CEO
Mr. Rausch is the CEO of Boston Therapeutics, overseeing operations in the US and in Asia. He is deeply involved in the restructuring of the company with an overhaul of operations for manufacture, clinical and regulatory as well as exploratory marketing. In 2014 to present, Mr. Rausch served as Managing Principal Partner of World Technology East II Ltd (WTE II), a Hong Kong based consulting firm involved with all aspects of biopharmaceutical product development, registration and licensing in various territories in Asia including Korea, Taiwan, Singapore, Myanmar, Brunei, Malaysia, Japan, China and Australia.
In 2014, Mr Rausch also served as the Principal of Medical Technology Associates II (MTA II), a Delaware corporation involved in the licensing, research development as well as manufacturing and marketing of innovative technology driven high technology processes in biologics and diagnostics.
Mr. Rausch Co-founded of Biopure Corporation ("Biopure") in 1984 and served as the Chairman, President, Vice Chairman and Chief Technical Officer of Biopure from 1984 to 2002 to 2005. Biopure grew to a market capitalization of over $1.2 billion USD in 2000 and left the leadership role in 2002.